HIV-associated neurocognitive disorders;Zaburzenia neuropoznawcze w przebiegu zakażenia wirusem HIV

Psychiatria Polska

Volumn 47, Issue 3, 2013, Pages 453-463

  Kalinowska, Sylwia ^a   Trześniowska Drukała, Beata ^a   Samochowiec, Jerzy ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

HIV associated cognitive motor complex

Indexed keywords

DILTIAZEM; INSULIN; NIMODIPINE; RIVASTIGMINE; VERAPAMIL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; POLAND; PRACTICE GUIDELINE; PREVALENCE; VIRUS ENTRY; ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM INFECTION; COMORBIDITY; FEMALE; HEALTH STATUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENTAL HEALTH; REVIEW; STATISTICS; VIROLOGY;

ADOLESCENT; ANTI-HIV AGENTS; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CENTRAL NERVOUS SYSTEM PARASITIC INFECTIONS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; COMORBIDITY; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; MENTAL HEALTH; NEUROPSYCHOLOGICAL TESTS; POLAND; YOUNG ADULT;

EID: 84879434644     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Singh D. What's in a Name? AIDS Dementia Complex, HIV-associated Dementia, HIV-associated neurocognitive disorder or HIV Encephalopathy. Afr J Psychiatry 2012; 15: 172-175.
2. Owe-Larsson B, Säll L,Salamon E, Allgulander C. HIV infection and psychiatric Illness. Afr J Psychiatry 2009; 12: 115-128.
3. Loewenstein RJ, Sharfstein SS. Neuropsychiatric aspects of acquired immune deficiency syndrome. Int J Psychiatry Med.1983-1984; 13(4): 255-60. (Pubitemid 14143289)
4. Gałażewska J. HIV i AIDS w Polsce. Serwis Informacyjny Narkomania. Krajowe Biuro ds. Przeciwdziałania Narkomanii. 2010; 4: 52.
5. Rosińska M, Gładysz A, Knysz B, Gasiorowski J, Inglot M, Rymer W, Szetela B, Fleischer K. Patogeneza, klinika i zakażenia oportunistyczne. W: Cianciara J, Juszczyk J. Choroby zakaźne i pasożytnicze, wyd. 1. Lublin: Czelej; 2007. p. 387-412.
6. Fernandez F, Giunta B, Tan J. Neuropsychiatryczne aspekty zakażenia ośrodkowego układu nerwowego ludzkim wirusem upośledzenia odporności. W: Wciórka J. red. Neuropsychiatria, wyd 1. Wrocław: Elsevier Urban &Partner; 2012. p. 363-382.
7. Kaul M, Lipton SA. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 2006; 1(2):138-151. (Pubitemid 44257489)
8. Albright AV, Soldan SS, González-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol 2003; 9(2): 222-27. (Pubitemid 36656455)
9. Jin J, Lam L, Sadic E, Fernandez F, Tan J, Giunta B. HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HAND. Am J Transl Res. 2012; 4(3): 302-315.
10. Kruman II, Nath A, Mattson MP. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol. 1998;154(2): 276-88. (Pubitemid 29044201)
11. Scaravilli F, Bazille C, Gray F. Neuropathologic contributions to understandning AIDS and the central nervous system. Brain Pathol 2007; 17(2): 197-208. (Pubitemid 46466132)
12. Adams MA, Ferraro FR. Acquired immunodeficiency syndrome dementia complex. J Clin Psychol 1997; 53(7): 767-78. (Pubitemid 27454580)
13. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 2003; 9(2): 205-21. (Pubitemid 36656454)
14. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19(6): 517-24. (Pubitemid 16085185)
15. Felgenhauer K. Another venereal disease with frequent nervous system involvement: neuro-AIDS. J Neurol 1987; 234(2): 65-6.
16. Thomas CS, Szabadi E. Paranoid psychosis as the first presentation of a fulminating lethal case of AIDS. Br J Psychiatry 1987; 151: 693-5. (Pubitemid 18025268)
17. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239(4840): 586-92. (Pubitemid 18066218)
18. Janssen RS, Cornblath DR, Epstein LG, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41(6): 778-85.
19. Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J. Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 2008; 20(1): 25-31. (Pubitemid 351196197)
20. Koutsilieri E, Scheller C, Sopper S, ter Meulen V, Riederer P. The pathogenesis of HIV-induced dementia. Mech Ageing Dev 2002; 123(8): 1047-1053. (Pubitemid 34603088)
21. Kaul M. HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Front Biosci 2008; 13:2484-2494. (Pubitemid 351599699)
22. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69(18):1789-1799. (Pubitemid 350059308)
23. Anthony IC, Bell JE. The Neuropathology of HIV/AIDS. Int Rev Psychiatry 2008; 20(1): 15-24. (Pubitemid 351196199)
24. von Giesen HJ, Haslinger BA, Rohe S, Köller H, Arendt G. HIV Dementia Scale and psychomotor slowing - the best methods in screening for neuro-AIDS. J Neuropsychiatry Clin Neurosci 2005; 17(2): 185-191. (Pubitemid 41350605)
25. Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P. Parkinsonism in HIV dementia. J Neural Transm 2002; 109(5-6): 767-775. (Pubitemid 34810772)
26. Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 2002; 8(3): 410-424. (Pubitemid 34296099)
27. Dunlop O, Björklund R, Bruun JN, Evensen R, Goplen AK, Liestöl K, Sannes M, Maehlen J, Myrvang B. Early psychomotor slowing predicts the development of HIV dementia and autopsy - verified HIV encephalitis. Acta Neurol Scand 2002; 105(4): 270-275. (Pubitemid 34407229)
28. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003; 9(2): 205-21. (Pubitemid 36656454)
29. McArthur JC, Brew BJ. HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS 2010; 24: 1367-1370.
30. Grant I. Neurocognitive disturbances in HIV 1. Int Rev Psychiatry 2008; 20: 33-47.
31. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 2005; 19(13): 1367-1374. (Pubitemid 41800672)
32. Jones BN, Teng EL, Folstein MF, Harrison KS. A new bedside test of cognition for patients with HIV infection. AnnInternMed 1993; 119:1001-1004. (Pubitemid 23334656)
33. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assesment (Fourth Edition). New York : Oxford University Press, 2004.
34. Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8(3): 273-278.
35. Pulik P, Horban A. Leczenie antyretrowirusowe - monitorowanie i rozpoczynanie leczenia antyretrowirusowego. W: Horban A, Podlasin R, Cholewińska G, Wiercińska-Drapało A, Knysz B, Inglot M, Szymczak A. red. Zasady opieki nad osobami zakażonymi HIV. Zalecenia Polskiego Towarzystwa Naukowego AIDS. 2012, Warszawa-Wrocław: Polskie Towarzystwo Naukowe AIDS; 2012. p. 52-60.
36. Cholewińska G, Szymańska B. Zaburzenia neuropsychologiczne u pacjentów z HIV/AIDS. W: Horban A, Podlasin R, Cholewińska G, Wiercińska-Drapało A, Knysz B, Inglot M, Szymczak A. red. Zasady opieki nad osobami zakażonymi HIV. Zalecenia Polskiego Towarzystwa Naukowego AIDS. 2012, Warszawa-Wrocław: Polskie Towarzystwo Naukowe AIDS; 2012. p. 345-356.
37. Alisky, Joseph Martin. Could Cholinesterase Inhibitors and Memantine Alleviate HIV Dementia? JAIDS. 2005; 38:113-114. (Pubitemid 40094130)
38. Simioni S, Cavassini M, Annoni JM, Métral M, Iglesias K, Abraham AR, Jilek S, Calmy A, Müller H, Fayet-Mello A, Giacobini E, Hirschel B, Du Pasquier RA. Rivastigmine for HIV-associated neurocognitive disorders: A randomized crossover pilot study. Neurology. 2013 Jan 23. [Epub ahead of print]
39. Nakasujja N, Miyahara S, Evans S, Lee A, Musisi S, Katabira E, Robertson K, Ronald A, Clifford DB, Sacktor N. Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology. 2013; 8; 80(2): 196-202.
40. Hanson LR, Frey WH, Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. J Neuroimmune Pharmacol. 2007 Mar;2(1): 81-86.
41. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002; 8(2): 136-142. (Pubitemid 34520894)
42. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 2005; 19(13): 1367-1374. (Pubitemid 41800672)
43. Evers S, Rahmann A, Schwaag S, Frese A, Reichelt D, Husstedt IW. Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance. AIDS Res Hum Retroviruses 2004; 20(5): 483-491. (Pubitemid 38720961)
44. Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 2002; 59(6): 923-928. (Pubitemid 34640751)
45. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Text Revision. DSM-IV TR. Arlington, VA. 2000.
46. Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: a rapid screening test. JAcquir Immune DeficSyndr Hum Retrovirol 1995; 8: 273-278.
47. Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Med 2009;10: 246-252.
48. Department of Health of South Africa. Clinical Guidelines for the Management of HIV & AIDS in Adults and Adolescents. Pretoria; 2010.
49. American Academy of Neurology. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Neurology 1991; 41: 778-785.
50. Kałwa A, Szymańska B, Cholewińska G, Siwy-Hudowska A: HIV/HCV Co-Infection. A Dual Neurocognitive Problem. World Journal of AIDS, 2012, 2: 33-41